Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Sonya Marshall-Gradisnik
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
[[File:Sonya Marshall-Gradisnik.png|thumb|right|Source: InvestinME]] '''Sonya M. Marshall-Gradisnik''', BSc (Hons), PhD, is director of the [[National Centre for Neuroimmunology and Emerging Diseases]] (NCNED) at [[Griffith University]] in [[Australia]].<ref>{{Cite web|url=https://experts.griffith.edu.au/19059-sonya-marshallgradisnik | title = Professor Sonya Marshall-Gradisnik | last = | first = | author-link = | last2 = | first2 = | authorlink2 = | date = | website = Griffith University|archive-url=|archive-date=|url-status=|access-date=2022-08-12}}</ref> Her expertise is in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] with particular focus on [[Natural killer cell|Natural Killer Cell]] function and signalling pathways, [[Regulatory T cell|T regulatory]] and [[B cell]] phenotypes and [[cytokine]] production, and transcriptional profiling and gene expression.<ref>https://www.griffith.edu.au/health/school-medical-science/staff/professor-sonya-marshall-gradisnik</ref> In her studies, she compares the changes of the different cells of the [[immune system]] in relation to the severity of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]. Professor Marshall-Gradisnik established the first [[Australia|Australian]] CFS/ME research/medical clinic at [[Griffith University]], which was developed in conjunction with Queensland Health and CFS public health programs and provides clinical support for patients and carers at Gold Cost University Hospital, Griffith University. Later she established a mobile CFS research clinic to ensure the most severely affected CFS patients are able to have medical attention as well as participate in research.<ref name=":2" /> == Awards == * Queensland Women in Technology Research Award Rising Star Award for her research into immunological biomarkers for CFS or ME in 2010<ref name=":1">{{Cite web|url=https://www.omicsonline.org/editor-profile/Sonya_Marshall_Gradisnik/ | title = Editor - Sonya Marshall-Gradisnik {{!}} Bond University {{!}} 5340 | website = omicsonline.org|language=en|access-date=2018-12-07}}</ref> * National Award as Best Young Science Investigator at the Australian Conference for Science and Medicine for her studies into natural killer cell function and genotyping<ref name=":1" /> * Finalist in Young Australian of the Year Award Science and Technology Category<ref name=":1" /> == Committees and writing boards == ====International Consensus Criteria==== 2011 - Marshall-Gradisnik co-authored the 2011 case definition, [[International Consensus Criteria]].<ref>{{Cite journal | last = Carruthers | first=Bruce M. | author-link = Bruce Carruthers | last2 = van de Sande | first2 = Marjorie I. | authorlink2 = Marjorie van de Sande | last3 = De Meirleir | first3=Kenny L. | authorlink3 = Kenny De Meirleir | last4 = Klimas | first4 = Nancy G. | author-link4 = Nancy Klimas | last5 = Broderick | first5 = Gordon | author-link5 = Gordon Broderick | last6 = Mitchell | first6 = Terry | author-link6 = Terry Mitchell | last7 = Staines | first7 = Donald | author-link7 = Donald Staines | last8 = Powles | first8 = A.C. Peter | author-link8 = A C Peter Powles | last9 = Speight | first9 = Nigel | authorlink9 = Nigel Speight | last10 = Vallings | first10 = Rosamund | authorlink10 = Rosamund Vallings | last11 = Bateman | first11 = Lucinda | authorlink11 = Lucinda Bateman | last12 = Baumgarten-Austrheim | first12 = Barbara | authorlink12 = Barbara Baumgarten-Austrheim | last13 = Bell | first13 = David | author-link13 = David Bell | last14 = Carlo-Stella | first14 = Nicoletta | author-link14 = Nicoletta Carlo-Stella | last15 = Chia | first15 = John | author-link15 = John Chia | last16 = Darragh | first16 = Austin | author-link16 = Austin Darragh | last17 = Jo | first17 = Daehyun | author-link17 = Daehyun Jo | last18 = Lewis | first18 = Donald | author-link18 = Donald Lewis | last19 = Light | first19 = Alan | author-link19 = Alan Light | last20 = Marshall-Gradisnik | first20 = Sonya | author-link20 = Sonya Marshall-Gradisnik | last21 = Mena | first21 = Ismael | author-link21 = Ismael Mena | last22 = Mikovits | first22 = Judy | author-link22 = Judy Mikovits | last23 = Miwa | first23 = Kunihisa | author-link23 = Kunihisa Miwa | last24 = Murovska | first24 = Modra | author-link24 = Modra Murovska | last25 = Pall | first25 = Martin | author-link25 = Martin Pall | last26 = Stevens | first26 = Staci | author-link26 = Staci Stevens | date = 2011-08-22 | title=Myalgic encephalomyelitis: International Consensus Criteria|url=https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2796.2011.02428.x|journal=Journal of Internal Medicine|language=en|volume=270|issue=4|pages=327–338|doi=10.1111/j.1365-2796.2011.02428.x|issn=0954-6820|pmc=3427890|pmid=21777306|via=}}</ref> ====International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis ==== Marshall-Gradisnik serves on the Board of Directors of the [[International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] (IACFS/ME).<ref name=":2">{{Cite web|url=http://iacfsme.org/Organization/Leadership-of-the-IACFS-ME/Sonya-Marshall-Gradisnik.aspx | title = Board Member-Sonya Marshall-Gradisnik, PhD | last = | first = | author-link = | date = |website=IACFSME|archive-url=|archive-date=|url-status=|access-date=2018-12-07}}</ref> Marshall-Gradisnik serves on the editorial board of the journal, [[Fatigue: Biomedicine, Health & Behavior]], published on behalf of the [[IACFS/ME]].<ref>{{Cite web|url=https://www.tandfonline.com/action/journalInformation?show=editorialBoard&journalCode=rftg20& | title = Fatigue: Biomedicine, Health & Behavior|website=tandfonline.com|access-date=2019-11-01}}</ref> ==== Austrialia National Health and Medical Research Council's ME and CFS advisory committee ==== 2018 - Prof Marshall-Gradisnik serves on the Australian government's National Health and Medical Research Council's ME and CFS advisory committee.<ref name=":0">{{Cite web|url=https://nhmrc.gov.au/myalgic-encephalomyelitis-and-chronic-fatigue-syndrome | title = Myalgic Encephalomyelitis and Chronic Fatigue Syndrome {{!}} NHMRC|website=nhmrc.gov.au|language=en|access-date=2018-12-06}}</ref> ==Biomarker Patent== In 2016, [[Griffith University]] filed for a patent for a [[Diagnostic biomarker|biological marker]] (Patent Publication number WO2016023077 A1)<ref name=":0" /> for the diagnosis and management of [[myalgic encephalomyelitis|ME]] and [[Chronic fatigue syndrome|CFS]]. Sonya Marshall-Gradisnik and [[Ekua Brenu]] are listed as the inventors. The application states: "The present invention resides broadly in the use of at least one miRNA as a [[Diagnostic biomarker|biological marker]] for identifying or diagnosing a subject having [[Chronic fatigue syndrome|CFS]] and/or [[myalgic encephalomyelitis|ME]]."<ref>{{Citation | title = Biological markers|url=https://patents.google.com/patent/WO2016023077A1/en|language=en|access-date=2019-09-01}}</ref> ==Notable studies== *2022, Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients<ref name="Eaton2022">{{Cite journal | title = Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients | date = 2022-02-16|url=https://doi.org/10.1186/s12967-022-03297-8|journal=Journal of Translational Medicine|volume=20|issue=1 | pages = 94 | last = Eaton-Fitch | first = Natalie | authorlink = Natalie Eaton-Fitch | last2 = Du Preez | first2 = Stanley | author-link2 = | last3 = Cabanas | first3=Hélène | authorlink3 = Hélène Cabanas | last4 = Muraki | first4 = Katsuhiko | authorlink4 = | last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik|doi=10.1186/s12967-022-03297-8|pmc=PMC8848670|pmid=35172836|access-date=|issn=1479-5876|quote=|via=}}</ref> - [https://dx.doi.org/10.1186/s12967-022-03297-8 (Full text)] *2022, Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="M2022">{{Cite journal | title = Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome | date = Jul 2022|url=https://onlinelibrary.wiley.com/doi/10.1002/jnr.25048|journal=Journal of Neuroscience Research|volume=100|issue=7|pages=1476–1486 | last = Thapaliya | first = Kiran | author-link = | last2 = Staines | first2 = Donald | author-link2 = Donald Staines | last3 = Marshall‐Gradisnik | first3 = Sonya | authorlink3 = Sonya Marshall-Gradisnik | last4 = Su | first4 = Jiasheng | authorlink4 = | last5 = Barnden | first5 = Leighton | authorlink5 = Leighton Barnden|language=en|doi=10.1002/jnr.25048|pmc=PMC9321967|pmid=35355311|access-date=|issn=0360-4012|quote=|via=}}</ref> - [https://dx.doi.org/10.1002/jnr.25048 (Full text)] *2022, Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Mb2022">{{Cite journal | title = Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | date = 2022 | url=https://www.frontiersin.org/articles/10.3389/fnins.2022.848730|journal=Frontiers in Neuroscience|volume=16|issue=|pages = | last = Thapaliya | first = Kiran | author-link = | last2 = Marshall-Gradisnik | first2 = Sonya | authorlink2 = Sonya Marshall-Gradisnik | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Su | first4 = Jiasheng | authorlink4 = | last5 = Barnden | first5 = Leighton | authorlink5 = Leighton Barnden|doi=10.3389/fnins.2022.848730|pmc=PMC9072664|pmid=35527811|access-date=|issn=1662-453X|quote=|via=}}</ref> - [https://dx.doi.org/10.3389/fnins.2022.848730 (Full text)] *2021, Potential implications of mammalian transient receptor potential melastatin 7 in the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome: A review<ref name="DuPreez2021m">{{Cite journal | title = Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review | date = Jan 2021|url=https://www.mdpi.com/1660-4601/18/20/10708|journal=International Journal of Environmental Research and Public Health|volume=18|issue=20|pages=10708 | last = Du Preez | first = Stanley | author-link = | last2 = Cabanas | first2 = Helene | author-link2 = Hélène Cabanas | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik|language=en|doi=10.3390/ijerph182010708|pmc=PMC8535478|pmid=34682454|access-date=|issn=1660-4601|quote=|via=}}</ref> - [https://dx.doi.org/10.3390/ijerph182010708 (Full text)] *2021, Network analysis of symptoms co-occurrence in chronic fatigue syndrome<ref name="Kujawski2021">{{Cite journal | title = Network Analysis of Symptoms Co-Occurrence in Chronic Fatigue Syndrome | date = Jan 2021|url=https://www.mdpi.com/1660-4601/18/20/10736|journal=International Journal of Environmental Research and Public Health|volume=18|issue=20|pages=10736 | last = Kujawski | first = Sławomir | author-link = | last2 = Słomko | first2 = Joanna | authorlink2 = | last3 = Newton | first3 = Julia L. | authorlink3 = Julia Newton | last4 = Eaton-Fitch | first4 = Natalie | author-link4 = Natalie Eaton-Fitch| last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | last7 = Zalewski | first7 = Paweł | authorlink7 = Paweł Zalewski|language=en|doi=10.3390/ijerph182010736|pmc=PMC8535251|pmid=34682478|issn=1660-4601|quote=|via=}}</ref> - [https://dx.doi.org/10.3390/ijerph182010736 (Full text)] *2021, Impact of life stressors on myalgic encephalomyelitis/chronic fatigue syndrome symptoms: An australian longitudinal study<ref name="Eaton2021s">{{Cite journal | title = Impact of Life Stressors on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms: An Australian Longitudinal Study | date = Jan 2021|url=https://www.mdpi.com/1660-4601/18/20/10614|journal=International Journal of Environmental Research and Public Health|volume=18|issue=20|pages=10614 | last = Balinas | first = Cassandra | author-link = | last2 = Eaton-Fitch | first2 = Natalie | author-link2 = Natalie Eaton-Fitch | last3 = Maksoud | first3=Rebekah | authorlink3 = | last4 = Staines | first4 = Donald | author-link4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|language=en|doi=10.3390/ijerph182010614|pmc=PMC8535742|pmid=34682360|access-date=|issn=1660-4601|quote=|via=}}</ref> - [https://dx.doi.org/10.3390/ijerph182010614 (Full text)] *2021, Diffusion tensor imaging reveals neuronal microstructural changes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Thapaliya2021">{{Cite journal | title = Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome | date = Sep 2021|url=https://onlinelibrary.wiley.com/doi/10.1111/ejn.15413|journal=European Journal of Neuroscience|volume=54|issue=6 | pages = 6214–6228 | last = Thapaliya | first = Kiran | author-link = | last2 = Marshall‐Gradisnik | first2 = Sonya | authorlink2 = Sonya Marshall-Gradisnik | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Barnden | first4 = Leighton | author-link4 = Leighton Barnden|language=en|doi=10.1111/ejn.15413|pmc=PMC9291819|pmid=34355438|access-date=|issn=0953-816X|quote=|via=}}</ref> - [https://dx.doi.org/10.1111/ejn.15413 (Full text)] *2021, Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients<ref name="DuPreez2021t2">{{Cite journal | title = Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients | date = Jan 2021|url=https://www.mdpi.com/1660-4601/18/22/11879/htm|journal=International Journal of Environmental Research and Public Health|volume=18|issue=22|pages=11879 | last = Du Preez | first = Stanley | author-link = | last2 = Eaton-Fitch | first2 = Natalie | author-link2 = Natalie Eaton-Fitch | last3 = Cabanas | first3=Helene | authorlink3 = Hélène Cabanas | last4 = Staines | first4 = Donald | author-link4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|language=en|doi=10.3390/ijerph182211879|pmc=PMC8618557|pmid=34831634|access-date=|issn=1660-4601|quote=|via=}}</ref> - [https://dx.doi.org/10.3390/ijerph182211879 (Full text)] *2021, Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Sukocheva2021">{{Cite journal | title = Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome | date = 2021-11-26|url=https://www.sciencedirect.com/science/article/pii/S2090123221002320|journal=Journal of Advanced Research | last = Sukocheva | first=Olga A. | last2 = Maksoud | first2 = Rebekah | last3 = Beeraka | first3=Narasimha M. | last4 = Madhunapantula | first4 = SabbaRao V. | last5 = Sinelnikov | first5 = Mikhail | last6 = Nikolenko | first6 = Vladimir N. | last7 = Neganova | first7 = Margarita E. | last8 = Klochkov | first8 = Sergey G. | last9 = Amjad Kamal | first9 = Mohammad | last10 = Staines | first10 = Donald R | authorlink10 = Donald Staines | last11 = Marshall-Gradisnik | first11 = Sonya | authorlink11 = Sonya Marshall-Gradisnik|language=en|doi=10.1016/j.jare.2021.11.013|pmc=PMC8619886|issn=2090-1232}}</ref> - [https://dx.doi.org/10.1016/j.jare.2021.11.013 (Full text)] *2021, A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Maksoud2021n">{{Cite journal | title = A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome | date = 2021-02-17|url=https://doi.org/10.1186/s12967-021-02742-4|journal=Journal of Translational Medicine|volume=19|issue=1 | pages = 81 | last = Maksoud | first = Rebekah | last2 = Balinas | first2 = Cassandra | last3 = Holden | first3=Sean | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik|doi=10.1186/s12967-021-02742-4|pmc=PMC7890871|pmid=33596913|issn=1479-5876}}</ref> - [https://dx.doi.org/10.1186/s12967-021-02742-4 (Full text)] *2021, A preliminary investigation of nutritional intake and supplement use in australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life<ref name="Weigel2021">{{Cite journal | title = A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life | date = 2021-06-07|url=https://foodandnutritionresearch.net/index.php/fnr/article/view/5730|journal=Food & Nutrition Research | last = Weigel | first = Breanna | last2 = Eaton-Fitch | first2 = Natalie | last3 = Passmore | first3 = Rachel | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik |language=en|doi=10.29219/fnr.v65.5730|pmc=PMC8254462|pmid=34262415|issn=1654-661X}}</ref> - [https://dx.doi.org/10.29219/fnr.v65.5730 (Full text)] *2021, The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients<ref name="Eaton2021t3">{{Cite journal | title = The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients | date = 2021-07-15|url=https://doi.org/10.1186/s12967-021-02974-4|journal=Journal of Translational Medicine|volume=19|issue=1|pages=306 | last = Eaton-Fitch | first = Natalie | authorlink = Natalie Eaton-Fitch | last2 = Cabanas | first2 = Hélène | author-link2 = Hélène Cabanas | last3 = du Preez | first3 = Stanley | last4 = Staines | first4 = Donald| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|doi=10.1186/s12967-021-02974-4|pmc=PMC8281618|pmid=34266470|issn=1479-5876}}</ref> - [https://dx.doi.org/10.1186/s12967-021-02974-4 (Full text)] *2021, Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment<ref name="Cabanas2021">{{Cite journal | title = Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment | date = 2021|url=https://www.frontiersin.org/articles/10.3389/fimmu.2021.687806|journal=Frontiers in Immunology|volume=12|issue= | pages = 687806 | last = Cabanas | first=Helene | authorlink = Hélène Cabanas | last2 = Muraki | first2 = Katsuhiko | authorlink2 = | last3 = Eaton-Fitch | first3 = Natalie | authorlink3 = Natalie Eaton-Fitch | last4 = Staines | first4 = Donald Ross | author-link4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|doi=10.3389/fimmu.2021.687806|pmc=PMC8313851|pmid=34326841|access-date=|issn=1664-3224|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2021.687806/full (Full text)] *2021, Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Maksoud2021">{{Cite journal | last = Maksoud | first = Rebekah | authorlink = | last2 = Eaton-Fitch | first2 = Natalie | author-link2 = Natalie Eaton-Fitch | last3 = Matula | first3=Michael | authorlink3 = | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | date = May 2021 | title = Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.mdpi.com/2227-9032/9/5/568/htm|journal=Healthcare|language=en|volume=9|issue=5|pages=568|doi=10.3390/healthcare9050568|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.mdpi.com/2227-9032/9/5/568/htm (Full text)] * 2020, Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study<ref>{{Cite journal | last = Eaton-Fitch | first = N. | author-link = Natalie Eaton-Fitch | last2 = Johnston | first2 = S.C. | authorlink2 = | last3 = Zalewski | first3 = P. | authorlink3 = | last4 = Staines | first4 = D. | authorlink4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = S. | authorlink5 = Sonya Marshall-Gradisnik | date = 2020-01-22 | title = Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study|url=http://link.springer.com/10.1007/s11136-019-02411-6|journal=Quality of Life Research|language=en|volume=|issue=|pages=|doi=10.1007/s11136-019-02411-6|issn=0962-9343|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://link.springer.com/article/10.1007%2Fs11136-019-02411-6 (Full text)] * 2020, Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans<ref name="Thapaliya2020">{{Cite journal | last = Thapaliya | first = Kiran | author-link = | last2 = Marshall-Gradisnik | first2 = Sonya | authorlink2 = Sonya Marshall-Gradisnik | last3 = Staines | first3=Don | authorlink3 = Donald Staines | last4 = Barnden | first4 = Leighton | author-link4 = Leighton Barnden | date = 2020 | title=Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans|url=https://linkinghub.elsevier.com/retrieve/pii/S2213158220302035|journal=NeuroImage: Clinical|language=en|volume=28|issue=|pages=102366|doi=10.1016/j.nicl.2020.102366|pmc = 7417892|pmid=32777701|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417892/ (Full text)] *2020, A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systematic exertion intolerance disease<ref>{{Cite journal | title = A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease | date = 2020-07-29|url=https://doi.org/10.1186/s12967-020-02452-3|journal=Journal of Translational Medicine|volume=18|issue=1|pages=290 | last = Holden | first = Sean | author-link = | last2 = Maksoud | first2 = Rebekah | authorlink2 = | last3 = Eaton-Fitch | first3 = Natalie | authorlink3 = Natalie Eaton-Fitch | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik|doi=10.1186/s12967-020-02452-3|pmc=PMC7392668|pmid=32727475|access-date=|issn=1479-5876|quote=|via=}}</ref><ref name="Correction2020">https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02575-7</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02452-3 (Full text)], [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02575-7 (Correction)] *2019, Epidemiology of paediatric chronic fatigue syndrome in Australia<ref name="Knight2019">{{Cite journal | last = Knight | first = Sarah | last2 = Elders | first2 = Shane | last3 = Rodda | first3 = Jill | last4 = Harvey | first4 = Adrienne| last5 = Lubitz | first5 = Lionel | last6 = Rowe | first6 = Kathy | authorlink6 = Kathy Rowe | last7 = Reveley | first7 = Colette | last8 = Hennel | first8 = Sabine | last9 = Towns | first9 = Susan | last10 = Kozlowska | first10 = Kasia | last11 = Payne | first11 = Donald N | last12 = Marshall-Gradisnik | first12 = Sonya | authorlink12=Sonya Marshall-Gradisnik | last13 = Scheinberg | first13 = Adam | date = 2019-02-23 | title = Epidemiology of paediatric chronic fatigue syndrome in Australia|url=http://adc.bmj.com/lookup/doi/10.1136/archdischild-2018-316450|journal=Archives of Disease in Childhood|language=en|pages=archdischild–2018–316450|doi=10.1136/archdischild-2018-316450|issn=0003-9888}}</ref> - [https://adc.bmj.com/content/early/2019/02/23/archdischild-2018-316450.full (Full text)] *2019, Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study<ref name="Slomko2019">{{Cite journal | last = Słomko | first = Joanna | author-link = | last2 = Newton | first2 = Julia L | authorlink2 = Julia Newton | last3 = Kujawski | first3 = Sławomir | authorlink3 = | last4 = Tafil-Klawe | first4 = Małgorzata | authorlink4 = | last5 = Klawe | first5 = Jacek | authorlink5 = | last6 = Staines | first6 = Donald | author-link6 = Donald Staines | last7 = Marshall-Gradisnik | first7 = Sonya | authorlink7 = Sonya Marshall-Gradisnik | last8 = Zalewski | first8 = Pawel | authorlink8 = Paweł Zalewski | date = Mar 2019 | title = Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study|url=http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2018-023955|journal=BMJ Open|language=en|volume=9|issue=3| pages = e023955|doi=10.1136/bmjopen-2018-023955|issn=2044-6055|pmc=|pmid=30850404|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429942/ (Full text)] *2019, Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients<ref>{{Cite journal | last = Cabanas | first=H. | author-link = Hélène Cabanas | last2 = Muraki | first2 = K. | authorlink2 = | last3 = Balinas | first3=C. | authorlink3 = | last4 = Eaton-Fitch | first4 = N. | authorlink4 = Natalie Eaton-Fitch| last5 = Staines | first5 = D. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | date = Dec 2019 | title = Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients|url=https://molmed.biomedcentral.com/articles/10.1186/s10020-019-0083-4|journal=Molecular Medicine|language=en|volume=25|issue=1|pages=|doi=10.1186/s10020-019-0083-4|issn=1076-1551|quote=|via=|pmc=|pmid=|access-date=}}</ref> - [https://link.springer.com/article/10.1186/s10020-019-0083-4 (Full text)] *2019, A systematic review of [[Cytokine|cytokines]] in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)<ref>{{Cite journal | last = Corbitt | first = Matthew | author-link = | last2 = Eaton-Fitch | first2 = Natalie | author-link2 = Natalie Eaton-Fitch | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Cabanas | first4 = Hélène | author-link4 = Hélène Cabanas| last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik | date = Dec 2019 | title = A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)|url=https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-019-1433-0|journal=BMC Neurology|language=en|volume=19|issue=1|pages=|doi=10.1186/s12883-019-1433-0|issn=1471-2377|pmc=|pmid=31445522|access-date=|quote=|via=}}</ref> - [https://link.springer.com/article/10.1186/s12883-019-1433-0#citeas (Full text)] * 2019, [[Low dose naltrexone|Naltrexone]] restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients<ref>{{Cite journal | last = Cabanas | first=Helene | authorlink = Hélène Cabanas | last2 = Muraki | first2 = Katsuhiko | authorlink2 = | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik | date = 14 Oct 2019 | title = Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients|url=https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/abstract|journal=Frontiers in Immunology|volume=|issue=|pages=|doi=10.3389/fimmu.2019.02545|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/abstract (Abstract)] * 2019, Intra [[brainstem]] connectivity is impaired in chronic fatigue syndrome<ref>{{Cite journal | last = Barnden | first = Leighton R | author-link = Leighton Barnden | last2 = Shan | first2 = Zack Y | authorlink2 = Zack Shan | last3 = Staines | first3=Donald R | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik| last5 = Finegan | first5 = Kevin | authorlink5 = | last6 = Ireland | first6 = Timothy | author-link6 = | last7 = Bhuta | first7 = Sandeep | date = 2019 | title=Intra brainstem connectivity is impaired in chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S2213158219303924|journal=NeuroImage: Clinical|language=en|volume=24|issue=|pages=102045|doi=10.1016/j.nicl.2019.102045|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.sciencedirect.com/science/article/pii/S2213158219303924 (Full text)] *2019, [[Transient receptor potential melastatin 2]] channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients<ref name="Balinas2019">{{Cite journal | last = Balinas | first = Cassandra | authorlink = Cassandra Balinas | last2 = Cabanas | first2 = Hélène | author-link2 = Hélène Cabanas | last3 = Staines | first3=Donald | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik | date = 2019-12-03 | title = Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients|url=https://doi.org/10.1186/s12967-019-02155-4|journal=Journal of Translational Medicine|volume=17|issue=1 | pages = 401|doi=10.1186/s12967-019-02155-4|issn=1479-5876|pmc = 6891975|pmid=31796045|access-date=|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-019-02155-4 (Full text)] *2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Gradisnik2018">{{Cite journal | last = Marshall-Gradisnik | first = Sonya | authorlink = Sonya Marshall-Gradisnik | last2 = Fretel | first2 = Marshall | author-link2 = | last3 = Eaton | first3=Natalie | authorlink3 = Natalie Eaton-Fitch | last4 = Cabanas | first4 = Helene | author-link4 = Hélène Cabanas| last5 = Balinas | first5 = Cassandra | authorlink5 = Cassandra Balinas | last6 = Gopalan | first6 = Vinod | last7 = Petersen | first7 = Daniel | authorlink7 = Daniel Peterson | last8 = Passmore | first8 = Rachel | last9 = Tang | first9 = Kevin | last10 = Haque | first10 = Mazhar | authorlink10 = | last11 = Lam | first11 = Alfred | authorlink11 = | last12 = Staines | first12 = Donald | authorlink12 = Donald Staines | date = 2018-05-31 | title = Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|url=http://www.scirp.org/journal/PaperInformation.aspx?PaperID=85005&#abstract|journal=International Journal of Clinical Medicine|language=en|volume=09|issue=05 | pages = 467|doi=10.4236/ijcm.2018.95040|via=|pmc=|pmid=|quote=|access-date=}}</ref> - [http://file.scirp.org/Html/11-2101759_85005.htm (Full text)] *2018, [[Brain]] function characteristics of [[chronic fatigue syndrome]]: A task fMRI study<ref name="Shan, 2018" /> - [https://www.sciencedirect.com/science/article/pii/S2213158218301347 (Full Text)] *2018, A Systematic Review of [[Probiotic]] Interventions for Gastrointestinal Symptoms and [[Irritable bowel syndrome|Irritable Bowel Syndrome]] in [[CFS/ME|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)]]<ref name="Corbitt, 2018" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29464501 (Abstract)] *2018, A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis<ref>{{Cite journal | last = Du Preez | first = S. | author-link = | last2 = Corbitt | first2 = M. | authorlink2 = | last3 = Cabanas | first3=H. | authorlink3 = Hélène Cabanas | last4 = Eaton | first4 = N. | authorlink4 = Natalie Eaton-Fitch| last5 = Staines | first5 = D. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | date = 2018-12-20 | title = A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis|url=https://doi.org/10.1186/s13643-018-0909-0|journal=Systematic Reviews|volume=7|issue=1|pages=241|doi=10.1186/s13643-018-0909-0|issn=2046-4053|pmc=|pmid=30572962|quote=|via=|access-date=}}</ref> - [https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0909-0 (Full text)] *2018, [[Rituximab]] impedes [[natural killer cell]] function in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients: A pilot in vitro investigation<ref name="Eaton2018R">{{Cite journal | last = Eaton | first = Natalie | authorlink = Natalie Eaton-Fitch | last2 = Cabanas | first2 = Hélène | author-link2 = Hélène Cabanas | last3 = Balinas | first3=Cassandra | authorlink3 = | last4 = Klein | first4 = Anne | author-link4 = | last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | date = Dec 2018 | title = Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation|url=https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-018-0203-8|journal=BMC Pharmacology and Toxicology|language=en|volume=19|issue=1|pages=12|doi=10.1186/s40360-018-0203-8|issn=2050-6511|pmc=5870391|pmid=29587879|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870391/ (Full Text)] *2018, Reduced glycolytic reserve in isolated [[natural killer cell]]s from [[ME/CFS|Myalgic encephalomyelitis/chronic fatigue syndrome]] patients: A preliminary investigation<ref name="Nguyen, 2018" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29981562 (Abstract)] *2018, Hyperintense sensorimotor T1 spin echo [[MRI]] is associated with brainstem abnormality in [[chronic fatigue syndrome]]<ref>{{Cite journal | last = Barnden | first = Leighton R. | last2 = Shan | first2 = Zack Y. | last3 = Staines | first3=Donald R. | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik| last5 = Finegan | first5 = Kevin | last6 = Ireland | first6 = Timothy | last7 = Bhuta | first7 = Sandeep | date = 2018 | title=Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome|url=https://www.sciencedirect.com/science/article/pii/S2213158218302237|journal=NeuroImage: Clinical|volume=20|pages=102-109|doi=10.1016/j.nicl.2018.07.011|via=}}</ref> - [https://www.sciencedirect.com/science/article/pii/S2213158218302237 (Full Text)] *2018, Loss of Transient Receptor Potential Melastatin 3 ion channel function in [[Natural killer cell|natural killer cells]] from [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref>{{Cite journal | last = Cabanas | first=Hélène | last2 = Muraki | first2 = Katsuhiko | last3 = Eaton | first3=Natalie | last4 = Balinas | first4 = Cassandra| last5 = Staines | first5 = Donald | author-link5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | date = 2018-08-14 | title = Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients|url=https://molmed.biomedcentral.com/articles/10.1186/s10020-018-0046-1|journal=Molecular Medicine|language=en|volume=24|issue=1|pages=|doi=10.1186/s10020-018-0046-1|issn=1076-1551|via=|pmc=|pmid=|quote= | author-link = Hélène Cabanas | author-link2 = |access-date= | authorlink3 = | authorlink4 = }}</ref> - [https://molmed.biomedcentral.com/articles/10.1186/s10020-018-0046-1 (Full Text)] *2018, Decreased Connectivity and Increased Blood Oxygenation Level Dependent Complexity in the Default Mode Network in Individuals with Chronic Fatigue Syndrome<ref>{{Cite journal | last = Shan | first = Zack Y. | author-link = | last2 = Finegan | first2 = Kevin | author-link2 = | last3 = Bhuta | first3=Sandeep | authorlink3 = | last4 = Ireland | first4 = Timothy | author-link4 = | last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya M. | authorlink6 = Sonya Marshall-Gradisnik | last7 = Barnden | first7 = Leighton R. | authorlink7 = | date = Feb 2018 | title = Decreased Connectivity and Increased Blood Oxygenation Level Dependent Complexity in the Default Mode Network in Individuals with Chronic Fatigue Syndrome | url = |journal=Brain Connectivity|volume=8|issue=1|pages=|doi=10.1089/brain.2017.0549|quote=|via=}}</ref> - [https://www.liebertpub.com/doi/abs/10.1089/brain.2017.0549 (Abstract)] *2017, Dietary and nutrition interventions for the therapeutic treatment of [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]]: a systematic review<ref>{{Cite journal | last = Campagnolo | first = N. | last2 = Johnston | first2 = S. | last3 = Collatz | first3 = A. | last4 = Staines | first4 = D. | authorlink4 = Donald Staines| last5 = Marshall-Gradisnik | first5 = S. | authorlink5 = Sonya Marshall-Gradisnik | date = 22 Jan 2017 | title = Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review | url =http://doi.wiley.com/10.1111/jhn.12435|journal=Journal of Human Nutrition and Dietetics|language=en|volume=30|issue=3|pages=247–259|doi=10.1111/jhn.12435|issn=0952-3871|pmc=|pmid=28111818|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434800/ (Full Text)] *2017, Impaired [[calcium]] mobilization in [[natural killer cell]]s from [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]] patients is associated with transient receptor potential melastatin 3 ion channels<ref name="Nguyen, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217865/ (Full Text)] *2017, Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]] patients<ref name="Nguyen, et al, 2017" /> - [http://apjai-journal.org/wp-content/uploads/2017/07/75-81-AP0771.pdf (Full Text)] *2016, ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− [[natural killer cell]]s in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref name="Huth, 2016" /> - [http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-016-0859-z (Full Text)] *2016, [[Natural killer cell]]s and single nucleotide polymorphisms of specific ion channels and receptor genes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Marshall-Gradisnik,SM 2016" /> - [https://www.dovepress.com/natural-killer-cells-and-single-nucleotide-polymorphisms-of-specific-i-peer-reviewed-fulltext-article-TACG (Full Text)] *2016, A Systematic Review of Drug Therapies for [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Collatz, 2016" /> - [https://www.ncbi.nlm.nih.gov/pubmed/27229907 (Abstract)] *2016, Progressive [[brain]] changes in patients with [[chronic fatigue syndrome]]: A longitudinal MRI study<ref name="Shan, 2016" /> - [https://www.scienceopen.com/document/read?vid=ac2948b6-48d1-4ebd-8f96-3a3c5a57f770 (Full Text)] *2016, [[Regulatory T cell|Regulatory T]], [[Natural killer T cell|natural killer T]] and γδ T cells in [[multiple sclerosis]] and [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]]: a comparison.<ref name="Ramos, 2016" /> - [http://apjai-journal.org/wp-content/uploads/2016/12/8RegulatoryTnaturalkillerAPJAIVol34No4December2016P300.pdf (Full Text)] *2016, [[Natural killer cell|Killer Cell]] Immunoglobulin-like Receptor Genotype and Haplotype Investigation of [[Natural killer cell|Natural Killer Cell]]s from an Australian Population of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] Patients<ref name="Huth,TK, 2016" /> - [http://www.la-press.com/redirect_fi...enotype-and-Haplotype-Invest.pdf&fileType=pdf (Full Text)] *2015, A Comparison of [[Cytokine]] Profiles of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and [[Multiple Sclerosis]] Patients<ref name="Wong, 2015" /> - [http://file.scirp.org/Html/10-2101204_60764.htm (Full Text)] *2015, [[Cytokines]] in the Cerebrospinal Fluids of Patients with [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Peterson, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365360/ (Full Text)] *2015, Serum Immune Proteins in Moderate and Severe [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] Patients<ref name="Hardcastle, 09052015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615236/ (Full Text)] *2015, Longitudinal analysis of immune abnormalities in varying severities of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref name="Hardcastle, 092015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568602/ (Full Text)] *2015, Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)<ref name="Hardcastle, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450981/ (Full Text)] *2015, Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in [[Chronic Fatigue Syndrome]] Patients<ref name="Marshall-Gradisnik, 2015" /> - [http://journals.sagepub.com/doi/pdf/10.4137/III.S25147 (Full Text)] *2014, Characterization of [[Natural killer cell|Natural Killer Cell]] Phenotypes in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Huth, 2014" /> - [https://www.omicsonline.org/open-access/characterization-of-natural-killer-cell-phenotypes-in-chronic-fatigue-syndrome-2155-9899.1000223.pdf (Full Text)] *2014, The Role of Adaptive and Innate Immune Cells in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="BrenuEW2014" /> - [https://www.researchgate.net/publication/259350347_The_Role_of_Adaptive_and_Innate_Immune_Cells_in_Chronic_Fatigue_Syndrome_Myalgic_Encephalomyelitis (Full Text)] *2014, Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)]]<ref name="Hardcastle, 2014" /> - [https://www.omicsonline.org/open-access/analysis-relationship-immune-dysfunction-symptom-severity-patients-chronic-fatigue-2155-9899.1000190.php?aid=22894 (Full Text)] *2013, The role of clinical guidelines for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]] in research settings<ref name="Johnston, 2013" /> - [https://www.tandfonline.com/doi/abs/10.1080/21641846.2013.860779 (Abstract)] *2012, The Effects of Influenza Vaccination on Immune Function<ref>{{cite journal | last1 = Brenu | first1 = Ekua W | author-link1 = Ekua Brenu | last2 = van Driel | first2 = Mieke L | authorlink2 = | last3 = Staines | first3 = Donald R | authorlink3 = Donald Staines | last4 = Kreijkamp-Kaspers | first4 = Sanne | authorlink4 = | last5 = Hardcastle | first5 = Sharni L | author-link5 = Sharni Hardcastle | last6 = Marshall-Gradisnik |first6 = Sonya M | authorlink6 = Sonya Marshall-Gradisnik| title=The Effects of Influenza Vaccination on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|journal=International Journal of Clinical Medicine|volume=3|issue=6 | page = 544-551| date = 2012 |doi=10.4236/ijcm.2012.36098|url= https://file.scirp.org/pdf/IJCM20120600017_29918208.pdf}}</ref> - [https://file.scirp.org/pdf/IJCM20120600017_29918208.pdf (Full Text)] *2011, Immunological abnormalities as potential [[biomarker]]s in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref>{{Cite journal | last = Brenu | first = Ekua W | authorlink = Ekua Brenu | last2 = van Driel | first2 = Mieke L | authorlink2 = | last3 = Staines | first3=Don R | authorlink3 = Donald Staines | last4 = Ashton | first4 = Kevin J | authorlink4 = | last5 = Ramos | first5 = Sandra B | authorlink5 = Sandra Ramos | last6 = Keane | first6 = James | author-link6 = | last7 = Klimas | first7 = Nancy G | authorlink7 = Nancy Klimas | last8 = Marshall-Gradisnik | first8 = Sonya M | authorlink8 = Sonya Marshall-Gradisnik| date = 2011 | title = Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|url=http://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-9-81|journal=Journal of Translational Medicine|language=en|volume=9|issue=1 | pages = 81|doi=10.1186/1479-5876-9-81|issn=1479-5876|pmc=3120691|pmid=21619669|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120691/ (Full Text)] == Advocacy == ====Open Letter to ''The Lancet''==== Three [[open letter to the Lancet | open letters to the editor of ''The Lancet'']] urged the editor to commission a fully independent review of the [[PACE trial]], which the journal had published in 2011. In 2016, Dr. Marshall-Gradisnik, along with 41 colleagues in the [[ME/CFS]] field, signed the second letter. In June 2018, Dr. Marshall-Gradisnik signed the third letter, along with approximately 100 colleagues. *10 February 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] *19 June 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] ==Clinic location== [[National Centre for Neuroimmunology and Emerging Diseases]] (NCNED) is located at [[Griffith University]] on the Gold Coast, Queensland, [[Australia]]. ==Talks and interviews== *2012, Speaker at the 7th Invest in ME International ME Conference [http://www.investinme.org/IIMEC7.shtml#dvd DVD available](no speech title given)] *2012, [https://vimeo.com/108545941 Keynote address by Prof Sonya Marshall-Gradisnik at Emerge Australia (formerly ME/CFS Australia (Victoria)) Awareness Week] *2014, [https://soundcloud.com/search?q=chronic%20fatigue%20syndrome "Professor Sonya Marshall-Gradisnik, Australia's foremost expert on chronic fatigue syndrome" interviewed on ABC Gold Coast] *2014, Speaker at the 9th Invest in ME International ME Conference [http://www.investinme.org/IIMEC9.shtml#dvd DVD available](no speech title given)] *2015, Speaker at the 10th Invest in ME International ME Conference [http://www.investinme.org/IIMEC910.shtml#dvd DVD available](no speech title given)] *2016, [http://www.abc.net.au/pm/content/2016/s4415928.htm Australian scientists make breakthrough in Chronic Fatigue Syndrome testing] *2018, [https://meaustralia.net/2018/12/05/meet-the-scientists-prof-sonya-marshall-gradisnik/ Meet the Scientists: Professor Sonya Marshall-Gradisnik], by Sasha Nimmo in [[ME Australia]] newsletter *Mar 13, 2019, ''[https://mecfsconference.org.au/videos/sonyamarshall-gradisnik/ Immunological & Calcium Signalling Define ME/CFS]'' given at the International Research Symposium, Geelong, Australia, sponsored by [[Emerge Australia]] (presentation with [[Donald Staines]]) *Oct 28, 2019, [https://www.abc.net.au/radio/newcastle/programs/mornings/chronic-fatigue/11645618 Breaking through the stigma of Chronic Fatigue Syndrome] interview by On Mornings with Kia Handley, ABC Newcastle radio ==Online presence== *[https://www.griffith.edu.au/health/school-medical-science/staff/professor-sonya-marshall-gradisnik Griffith University - Sonya Marshall-Gradisnik] *[https://www.griffith.edu.au/health/national-centre-neuroimmunology-emerging-diseases National Centre for Neuroimmunology and Emerging Diseases] *[https://www.ncbi.nlm.nih.gov/pubmed/?term=Marshall-Gradisnik%20S%5BAuthor%5D&cauthor=true&cauthor_uid=26881265 PubMed - Sonya Marshall-Gradisnik] ==See also== *[[Diagnostic biomarker]] *[[Donald Staines]] *[[Ekua Brenu]] *[[National Centre for Neuroimmunology and Emerging Diseases]] ==News and interviews == *2022, [https://news.griffith.edu.au/2022/08/11/world-first-chronic-fatigue-syndrome-findings-could-fast-track-response-to-long-covid/ World first chronic fatigue syndrome findings could fast track response to Long COVID] - Griffith News, Griffith University *2014, [http://www.goldcoastbulletin.com.au/news/gold-coast/gold-coasts-griffith-university-to-lead-way-in-the-battle-against-chronic-fatigue/news-story/44ace31ee2ffac6277efa72bc4024142 "Gold Coast’s Griffith University to lead way in the battle against chronic fatigue"] - Gold Coast Bulletin *2016, [https://www.scimex.org/newsfeed/closer-to-a-full-understanding-of-chronic-fatigue-syndrome Closer to a Full Understanding of chronic fatigue syndrome] - Science Media Exchange (registration needed) ==Learn more == ==References== <references> <ref name="BrenuEW2014">{{citation | last1 = Brenu | first1 = EW | authorlink1 = Ekua Brenu | last2 = Huth | first2 = TK | authorlink2 = Teilah Huth | last3 = Hardcastle | first3 = SL | authorlink3 = Sharni Hardcastle | last4 = Fuller | first4 = K | authorlink4 = | last5 = Kaur | first5 = M | authorlink5 = | last6 = Johnston | first6 = S | authorlink6 = | last7 = Ramos | first7 = S | authorlink7 = Sandra Ramos | last8 = Staines | first8 = D | authorlink8 = Donald Staines | last9 = Marshall-Gradisnik | first9 = S | authorlink9 = Sonya Marshall-Gradisnik | title = The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis | journal = International Immunology | year = 2014 | volume = 26 | issue = 4 | page = 233-42 | pmid = 24343819 | doi = 10.1093/intimm/dxt068 }}</ref> <ref name="Corbitt, 2018">{{Citation | last1 = Corbitt | first1 = M | authorlink1 = | last2 = Campagnolo | first2 = N | authorlink2 = | last3 = Staines | first3 = D | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = S | authorlink4 = Sonya Marshall-Gradisnik | title = A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) | journal = Probiotics Antimicrob Proteins | volume = | issue = | page = | date = 2018 | pmid = | doi = 10.1007/s12602-018-9397-8 }}</ref> <ref name="Collatz, 2016">{{Citation | last1 = Collatz | first1 = Ansel | authorlink1 = | last2 = Johnston | first2 = Samantha C. | authorlink2 = | last3 = Staines | first3 = Donald R. | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya M. | authorlink4 = Sonya Marshall-Gradisnik | title = A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | journal = Clinical Therapeutics | volume =38 | issue = 6 | page = 1263-1271.e9 | date = 2016 | pmid = 27229907 | doi = 10.1016/j.clinthera.2016.04.038 }}</ref> <ref name="Hardcastle, 2014">{{Citation | last1 = Hardcastle | first1 = Sharni L. | authorlink1 = Sharni Hardcastle | last2 = Brenu | first2 = Ekua W. | authorlink2 = Ekua Brenu | last3 = Johnston | first3 = Samantha | authorlink3 = | last4 = Nguyen | first4 = Thao | authorlink4 = | last5 = Huth | first5 = Teilah K. | authorlink5 = Teilah Huth | last6 = Kaur | first6 = Manprit | authorlink6 = | last7 = Ramos | first7 = Sandra | authorlink7 = Sandra Ramos | last8 = Salajegheh | first8 = Ali | authorlink8 = | last9 = Staines | first9 = Donald R. | authorlink9 = Donald Staines | last10 = Marshall-Gradisnik | first10 = Sonya | authorlink10 = Sonya Marshall-Gradisnik | title = Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) | journal = Journal of Clinical & Cellular Immunology | volume = 5 | issue = 190 | page = | date = 2014 | pmid = | doi = 10.4172/2155-9899.1000190 }}</ref> <ref name="Hardcastle, 2015">{{Citation | last1 = Hardcastle | first1 = SL | authorlink1 = Sharni Hardcastle | last2 = Brenu | first2 = EW | authorlink2 = Ekua Brenu | last3 = Johnston | first3 = S | authorlink3 = | last4 = Nguyen | first4 = T | authorlink4 = | last5 = Huth | first5 = T | authorlink5 = Teilah Huth | last6 = Wong | first6 = N | authorlink6 = | last7 = Ramos | first7 = S | authorlink7 = Sandra Ramos | last8 = Staines | first8 = DR | authorlink8 = Donald Staines | last9 = Marshall-Gradisnik | first9 = SM | authorlink9 = Sonya Marshall-Gradisnik | title = Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) | journal = BMC Immunology | volume = 16 | issue = 35 | page = | date = 2015 | doi = 10.1186/s12865-015-0101-4 }}</ref> <ref name="Hardcastle, 092015">{{Citation | last1 = Hardcastle | first1 = Sharni Lee | authorlink1 = Sharni Hardcastle | last2 = Brenu | first2 = Ekua Weba | authorlink2 = Ekua Brenu | last3 = Johnston | first3 = Samantha| authorlink3 = | last4 = Nguyen | first4 = Thao | authorlink4 = | last5 = Huth | first5 = Teilah | authorlink5 = Teilah Huth | last6 = Ramos | first6 = Sandra| authorlink6 = Sandra Ramos | last7 = Staines | first7 = Donald | authorlink7 = Donald Staines | last8 = Marshall-Gradisnik | first8 = Sonya | authorlink8 = Sonya Marshall-Gradisnik | title = Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients | journal = Journal of Translational Medicine | volume = 13 | issue = 299 | page = | date = 2015 | doi = 10.1186/s12967-015-0653-3 }}</ref> <ref name="Hardcastle, 09052015">{{Citation | last1 = Hardcastle | first1 = SL | authorlink1 = Sharni Hardcastle | last2 = Brenu | first2 = EW | authorlink2 = Ekua Brenu | last3 = Johnston | first3 = S | authorlink3 = | last4 = Nguyen | first4 = T | authorlink4 = | last5 = Huth | first5 = T | authorlink5 = Teilah Huth | last6 = Wong | first6 = N | authorlink6 = | last7 = Ramos | first7 = S | authorlink7 = Sandra Ramos | last8 = Staines | first8 = DR | authorlink8 = Donald Staines | last9 = Marshall-Gradisnik | first9 = SM | authorlink9 = Sonya Marshall-Gradisnik | title = Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients | journal = International Journal of Medical Sciences | volume = 12 | issue = 10 | page = 764-772 | date = 2015 | doi = 10.7150/ijms.12399 }}</ref> <ref name="Huth, 2014">{{Citation | last1 = Huth | first1 = Teilah K. | authorlink1 = Teilah Huth | last2 = Brenu | first2 = Ekua | authorlink2 = Ekua Brenu | last3 = Nguyen | first3 = Thao | authorlink3 = | last4 = Hardcastle | first4 = Sharni L. | authorlink4 = Sharni Hardcastle | last5 = Johnston | first5 = Samantha | authorlink5 = | last6 = Ramos | first6 = Sandra | authorlink6 = | last7 = Staines | first7 = Donald R. | authorlink7 = Donald Staines | last8 = Marshall-Gradisnik | first8 = Sonya M. | authorlink8 = Sonya Marshall-Gradisnik | title = Characterization of Natural Killer Cell Phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | journal = Journal of Clinical & Cellular Immunology | volume = 5 | issue = 3 | page = | date = 2014 | pmid = | doi = 10.4172/2155-9899.1000223 }}</ref> <ref name="Huth, 2016">{{Citation | last1 = Huth | first1 = Teilah K. | authorlink1 = Teilah Huth | last2 = Staines | first2 = Donald | authorlink2 = Donald Staines | last3 = Marshall-Gradisnik | first3 = Sonya| authorlink3 = Sonya Marshall-Gradisnik | title = ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients | journal = Journal of Translational Medicine | volume = 14 | issue = 97 | page = | date = 2016 | pmid = | doi = 10.1186/s12967-016-0859-z }}</ref> <ref name="Huth,TK, 2016">{{Citation | last1 = Huth | first1 = T.K. | authorlink1 = Teilah Huth | last2 = Brenu | first2 = E.W. | authorlink2 = Ekua Brenu | last3 = Staines | first3 = D.R. | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = S.M. | authorlink4 = Sonya Marshall-Gradisnik | title = Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients | journal = Gene Regulation and Systems Biology | volume = 10 | issue = | page = 43–49 | date = 2016 | pmid = | doi = 10.4137/GRSB.S39861 }}</ref> <ref name="Johnston, 2013">{{Citation | last1 = Johnston | first1 = S.C. | authorlink1 = | last2 = Brenu | first2 = E.W. | authorlink2 = Ekua Brenu | last3 = Staines | first3 = D.R. | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = S.M. | authorlink4 = Sonya Marshall-Gradisnik | title = The role of clinical guidelines for chronic fatigue syndrome/myalgic encephalomyelitis in research settings. | journal = Fatigue: Biomedicine, Health & Behavior | volume = 2 | issue = 1 | page = 28-39 | date = 2013 | doi = 10.1080/21641846.2013.860779 }}</ref> <ref name="Marshall-Gradisnik, 2015">{{Citation | last1 = Marshall-Gradisnik | first1 = Sonya M. | authorlink1 = Sonya Marshall-Gradisnik | last2 = Smith | first2 = Peter | authorlink2 = | last3 = Brenu | first3 = Ekua W. | authorlink3 = Ekua Brenu | last4 = Nilius | first4 = Bernd | authorlink4 = | last5 = Ramos | first5 = Sandra B. | authorlink5 = Sandra Ramos | last6 = Staines | first6 = Donald R. | authorlink6 = Donald Staines | title = Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients | journal = Immunology and Immunogenetics Insights | volume = 2015 | issue = 7 | page = 1-6 | date = 2015 | pmid = | doi = 10.4137/III.S25147 | url = http://insights.sagepub.com/examination-of-single-nucleotide-polymorphisms-snps-in-transient-recep-article-a4824 }}</ref> <ref name="Marshall-Gradisnik,SM 2016">{{Citation | last1 = Marshall-Gradisnik | first1 = Sonya M. | authorlink1 = Sonya Marshall-Gradisnik | last2 = Huth | first2 = Teilah | authorlink2 = Teilah Huth | last3 = Chacko | first3 = Anu | authorlink3 = | last4 = Johnston | first4 = Samantha| authorlink4 = | last5 = Smith | first5 = Peter| authorlink5 = | last6 = Staines | first6 = Donald R. | authorlink6 = Donald Staines | title = Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome | journal = The Application of Clinical Genetics | volume = 9 | issue = | page = 39—47 | date = 2016 | pmid = | doi = 10.2147/TACG.S99405 }}</ref> <ref name="Nguyen, 2017">{{Citation | last1 = Nguyen | first1 = T. | authorlink1 = | last2 = Hardcastle | first2 = S. | authorlink2 = Sharni Hardcastle | last3 = Clarke | first3 = L. | authorlink3 = | last4 = Smith | first4 = P. | authorlink4= | last5 = Staines | first5 = D. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | title = Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels | journal = Clinical and Experimental Immunology | volume = 187 | issue = 2 | page = 284–293 | date = 2017 | doi = 10.1111/cei.12882 }}</ref> <ref name="Nguyen, et al, 2017">{{Citation | last1 = Nguyen | first1 = T. | authorlink1 = | last2 = Johnston | first2 = S. | authorlink2 = | last3 = Chacko | first3 = A. | authorlink3 = | last4 = Gibson | first4 = D. | authorlink4 = | last5 = Cepon | first5 = J. | authorlink5 = | last6 = Smith | first6 = D. | authorlink6 = | last7 = Staines | first7 = D. | authorlink7 = Donald Staines | last8 = Marshall-Gradisnik | first8 = S. | authorlink8 = Sonya Marshall-Gradisnik | title = Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients | journal = Asian Pac J Allergy Immunol | volume = 35 | issue = 2 | page = 75-81 | date = 2017 | doi = 10.12932/AP0771 }}</ref> <ref name="Nguyen, 2018">{{Citation | last1 = Nguyen | first1 = T. | authorlink1 = | last2 = Staines | first2 = D. | authorlink2 = Donald Staines | last3 = Johnston | first3 = S. | authorlink3 = | last4 = Marshall-Gradisnik | first4 = S. | authorlink4 = Sonya Marshall-Gradisnik | title = Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation | journal = Asian Pac J Allergy Immunol | volume = | issue = | page = | date = Jul 2018 | doi = 10.12932/AP-011117-0188 }}</ref> <ref name="Peterson, 2015">{{Citation | last1 = Peterson | first1 = D | authorlink1 = Daniel Peterson | last2 = Brenu | first2 = EW | authorlink2 = Ekua Brenu | last3 = Gottschalk | first3 = G | authorlink3 = Gunnar Gottschalk | last4 = Ramos | first4 = Sandra B | authorlink4 = Sandra Ramos | last5 = Nguyen | first5 = T | authorlink5 = | last6 = Staines | first6 = D | authorlink6 = Donald Staines | last7 = Marshall-Gradisnik | first7 = S | authorlink7 = Sonya Marshall-Gradisnik | title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | journal = Mediators of Inflammation | volume = 2015 | issue = | page = | date = 2015 | doi = 10.1155/2015/929720 }}</ref> <ref name="Ramos, 2016">{{Citation | last1 = Ramos | first1 = S | authorlink1 = Sandra Ramos | last2 = Brenu | first2 = E | authorlink2 = Ekua Brenu | last3 = Broadley | first3 = S | authorlink3 = | last4 = Kwiatek | first4 = R | authorlink4 = Richard Kwiatek | last5 = Ng | first5 = J | authorlink5 = | last6 = Nguyen | first6 = T | authorlink6 = | last7 = Freeman | first7 = S | authorlink7 = | last8 = Staines | first8 = D | authorlink8 = Donald Staines | last9 = Marshall-Gradisnik | first9 = S | authorlink9 = Sonya Marshall-Gradisnik | title = Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison | journal = Asian Pac J Allergy Immunol | volume = 2016 | issue = 34 | page = 300-305 | date = 20 March 2016 | doi = 10.12932/AP0733 | url = http://apjai-journal.org/wp-content/uploads/2016/12/8RegulatoryTnaturalkillerAPJAIVol34No4December2016P300.pdf }}</ref> <ref name="Shan, 2016">{{Citation | last1 = Shan | first1 = Zack Y. | authorlink1 =Zack Shan | last2 = Kwiatek | first2 = Richard | authorlink2 = Richard Kwiatek | last3 = Burnet | first3 = Richard | authorlink3 =Richard Burnet | last4 = Del Fante | first4 = Peter | authorlink4 =Peter Del Fante | last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | last6 = Marshall‐Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | last7 = Barnden | first7 = Leighton R. | authorlink7 =Leighton Barnden | title = Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study | journal = Journal of Magnetic Resonance Imaging | volume = 44 | issue = | page = 1301–1311 | date = 2016 | pmid = | doi = 10.1002/jmri.25283 }}</ref> <ref name="Shan, 2018">{{Citation | last1 = Shan | first1 = Zack Y. | authorlink1 = | last2 = Finegan | first2 = Kevin | authorlink2 = | last3 = Bhuta | first3 = Sandeep| authorlink3 = | last4 = Ireland | first4 = Timothy| authorlink4 = | last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | last6 = Marshall‐Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | last7 = Barnden | first7 = Leighton R. | authorlink7 = | title = Brain function characteristics of [[chronic fatigue syndrome]]: A task fMRI study | journal = NeuroImage: Clinical | volume = 19 | issue = | page = 279-286 | date = 2018 | pmid = | doi = 10.1016/j.nicl.2018.04.025 }}</ref> <ref name="Wong, 2015">{{Citation | last1 = Wong | first1 = Naomi | authorlink1 = | last2 = Nguyen | first2 = Thao | authorlink2 = | last3 = Brenu | first3 = Ekua Weba| authorlink3 = Ekua Brenu | last4 = Broadley | first4 = Simon | authorlink4 = | last5 = Staines | first5 = Donald | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | title = A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients | journal = International Journal of Clinical Medicine | volume = 6 | issue = 10 | page = 769-783 | date = 2015 | pmid = | doi = 10.4236/ijcm.2015.610103 }}</ref> </references> [[Category:Researchers]] [[Category:Australia researchers]] [[Category:Clinicians]] [[Category:Australian clinicians]] [[Category:Psychological paradigm critics]] [[Category:PACE trial critics]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Citation
(
edit
)
Template:Cite journal
(
edit
)
Template:Cite web
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:No globals
(
edit
)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs